Skip to main content

Alan
Lyles
,
ScD

Associate Professor
-
Adjunct
Alan Lyles

Departmental Affiliations

Contact Info

410-837-6175

Research Interests

  • Access to medicines
  • Health Insurance, Pharmacoeconomics
  • Public Programs and Private Initiatives in Pharmaceutical Benefits
  • Drug Use Review (DUR)
  • Quantitative Reasoning in Professional Education
Experiences & Accomplishments
Education
ScD
MPH
Overview

Access to pharmaceuticals (policy, benefits and evidence); public, private and third sector arrangements; and professional education for quantitative reasoning.

Honors & Awards

Distinguished Teaching Award, College of Public Affairs. University of Baltimore. (2014-2015)


Fulbright Specialist. University of Helsinki Faculty of Pharmacy. (2011)


Fellow, National Academy of Public Administration (2008-present) ;


Docent of Pharmaceutical Policy and Pharmacoeconomics, University of Helsinki. (2007)


Fulbright Senior Specialist. University of Helsinki Faculty of Pharmacy. (2007)


President’s Faculty Award, University of Baltimore. (2007)


Visiting Chair in Pharmacoeconomics, University of Helsinki. (2006)


Distinguished Chair in Research and Scholarship, Yale Gordon College of Liberal Arts, University of Baltimore. (2005)


Advising, Mentoring and Teaching Recognition Award, Student Assembly of the Johns Hopkins University School of Public Health. (May 1999)


Faculty Recognition Award, Student Coordinating Committee of the Department of Health Policy and Management, Johns Hopkins University School of Public Health. (May 1999)


John Chancellor Hume Award for Significance of Doctoral Research in Health Policy and Management, The Johns Hopkins University. (1986)


Delta Omega, Alpha Chapter, Public Health Honor Society. (1986)


Valedictorian, University of Maryland School of Pharmacy, 1980 (Gold Medal for General Excellence).

Select Publications

Selected recent publications

  •  

    Fulda TR, Lyles A and Wertheimer A (editors). Pharmaceutical Public Policy. ISBN-13: 978-1498748506 Forthcoming (April 2016).

     

    1.  

      Lyles A. The Policy Process. Chapter in Fulda TR, Lyles A and Wertheimer A (editors). Pharmaceutical Public Policy. Boca Raton, CRC Press. ISBN-13: 978-1498748506 Forthcoming (April 2016).

       

    2.  

      Lyles A. Pharmaceutical Promotion. Chapter in Fulda TR, Lyles A and Wertheimer A (editors). Pharmaceutical Public Policy. Boca Raton, CRC Press. ISBN-13: 978-1498748506 Forthcoming (April 2016).

       

    3. Lyles A. (2015). The Political Landscape’s Relation to the Health and Wealth of Nations. [Chapter 5] in Nash DB, Fabius RJ, Skoufalos A, Clarke JL and Horowitz MR. (Eds.). Population Health: Creating a Culture of Wellness. Sudbury, MA: Jones and Bartlett Learning. ISBN: 978-1-284-04792-9

       

    4.  

      Lyles A. Biosimilars: Patient and Physician Acceptability is the Fifth Hurdle to Market Competition. Generics and Biosimilars Initiative Journal. 2015;4(1):6-7.